FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2128187135> ?p ?o ?g. }

• W2128187135 endingPage "219" @default.
• W2128187135 startingPage "217" @default.
• W2128187135 abstract "Journal of Interferon ResearchVol. 14, No. 4 Roferon (rIFN-α2a) Is More Immunogenic Than Intron A (rIFN-α2b) in Patients with Chronic Myelogenous LeukemiaP. VON WUSSOW, R. HEHLMANN, T. HOCHHAUS, D. JAKSCHIES, K.U. NOLTE, O. PRÜMMER, H. ANSARI, J. HASFORD, H. HEIMPEL, and H. DEICHERP. VON WUSSOWSearch for more papers by this author, R. HEHLMANNSearch for more papers by this author, T. HOCHHAUSSearch for more papers by this author, D. JAKSCHIESSearch for more papers by this author, K.U. NOLTESearch for more papers by this author, O. PRÜMMERSearch for more papers by this author, H. ANSARISearch for more papers by this author, J. HASFORDSearch for more papers by this author, H. HEIMPELSearch for more papers by this author, and H. DEICHERSearch for more papers by this authorPublished Online:5 May 2009https://doi.org/10.1089/jir.1994.14.217AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited ByBiologic Drugs for the Treatment of Noninfectious Uveitis1 January 2021 | Asia-Pacific Journal of Ophthalmology, Vol. 10, No. 1Interferons and Intravenous Immunoglobulin13 September 2019Interferon alfaImmunoproteomics: Current Technology and Applications19 July 2013Improved analytical methods for the detection and quantification of neutralizing antibodies to biopharmaceuticalsBioanalysis, Vol. 4, No. 17Interferon alpha 2b in the Treatment of Uveitic Cystoid Macular Edema12 March 2012 | Ocular Immunology and Inflammation, Vol. 20, No. 2Impact of Product-Related Factors on Immunogenicity of BiotherapeuticsJournal of Pharmaceutical Sciences, Vol. 100, No. 2Development of a Protein Biochip to Identify 6 Monoclonal Antibodies Against Subtypes of Recombinant Human Interferons4 May 2010 | ASSAY and Drug Development Technologies, Vol. 8, No. 2CYTOKINES AND CYTOKINE MODULATORSANTIVIRAL DRUGS, INCLUDING IMMUNOGLOBULINS AND INTERFERONSInterferons: therapy for cancerInterferon alfaStrategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicalsJournal of Immunological Methods, Vol. 278, No. 1-2Interferons: therapy for cancerCUTANEOUS T-CELL LYMPHOMADermatologic Clinics, Vol. 19, No. 4Natural And Induced Anticytokine Antibodies In Humans1 December 2009Detection and Characterization of Antibodies to PEG-IFN-alpha2b Using Surface Plasmon Resonance7 July 2004 | Journal of Interferon & Cytokine Research, Vol. 19, No. 7A comparison of four types of interferon alpha in the treatment of chronic hepatitis CCurrent Therapeutic Research, Vol. 59, No. 1The Biology of Interferon-α and the Clinical Significance of Anti-Interferon Antibodies1 July 2009 | Leukemia & Lymphoma, Vol. 29, No. 3-4Interferons: Therapy in CancerNeutralising and binding anti-interferon-β-1 b (IFN-b-1 b) antibodies during IFN-β-1 b treatment of multiple sclerosis2 July 2016 | Multiple Sclerosis Journal, Vol. 3, No. 3Determination of Interferon-α2 Allele Composition in the Genomic DNA from Healthy Volunteers and Leukemic Patients in Japan28 March 2009 | Journal of Interferon & Cytokine Research, Vol. 17, No. 3Antibodies to Interferon-α in Treated Cancer Patients: Incidence and Significance28 March 2009 | Journal of Interferon & Cytokine Research, Vol. 17, No. 3Epitopes recognized by neutralizing therapy-induced human anti-interferon-α antibodies are localized within the N-terminal functional domain of recombinant interferon-α2European Journal of Immunology, Vol. 26, No. 9The naming of cats—and alpha-interferonsThe Lancet, Vol. 348, No. 9024Chronic myelogenous leukemia: an update on the biological findings and therapeutic approachesCritical Reviews in Oncology/Hematology, Vol. 22, No. 3Human leukocyte interferon alpha: Structure, pharmacology, and therapeutic applicationsMedicinal Research Reviews, Vol. 15, No. 5Interferon-α-2a30 October 2012 | Clinical Immunotherapeutics, Vol. 4, No. 2Drugs acting on the immune system Volume 14Issue 4Aug 1994 To cite this article:P. VON WUSSOW, R. HEHLMANN, T. HOCHHAUS, D. JAKSCHIES, K.U. NOLTE, O. PRÜMMER, H. ANSARI, J. HASFORD, H. HEIMPEL, and H. DEICHER.Roferon (rIFN-α2a) Is More Immunogenic Than Intron A (rIFN-α2b) in Patients with Chronic Myelogenous Leukemia.Journal of Interferon Research.Aug 1994.217-219.http://doi.org/10.1089/jir.1994.14.217Published in Volume: 14 Issue 4: May 5, 2009PDF download" @default.
• W2128187135 created "2016-06-24" @default.
• W2128187135 creator A5023445898 @default.
• W2128187135 creator A5032925254 @default.
• W2128187135 creator A5035707250 @default.
• W2128187135 creator A5038451587 @default.
• W2128187135 creator A5059711428 @default.
• W2128187135 creator A5060363489 @default.
• W2128187135 creator A5070685325 @default.
• W2128187135 creator A5071724466 @default.
• W2128187135 creator A5076276301 @default.
• W2128187135 creator A5076726477 @default.
• W2128187135 date "1994-08-01" @default.
• W2128187135 modified "2023-09-26" @default.
• W2128187135 title "Roferon (rIFN-α_2a) Is More Immunogenic Than Intron A (rIFN-α_2b) in Patients with Chronic Myelogenous Leukemia" @default.
• W2128187135 cites W171106102 @default.
• W2128187135 cites W1978860220 @default.
• W2128187135 cites W2124918726 @default.
• W2128187135 cites W2164088012 @default.
• W2128187135 cites W4248161356 @default.
• W2128187135 doi "https://doi.org/10.1089/jir.1994.14.217" @default.
• W2128187135 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7822880" @default.
• W2128187135 hasPublicationYear "1994" @default.
• W2128187135 type Work @default.
• W2128187135 sameAs 2128187135 @default.
• W2128187135 citedByCount "32" @default.
• W2128187135 countsByYear W21281871352012 @default.
• W2128187135 countsByYear W21281871352013 @default.
• W2128187135 countsByYear W21281871352019 @default.
• W2128187135 countsByYear W21281871352021 @default.
• W2128187135 crossrefType "journal-article" @default.
• W2128187135 hasAuthorship W2128187135A5023445898 @default.
• W2128187135 hasAuthorship W2128187135A5032925254 @default.
• W2128187135 hasAuthorship W2128187135A5035707250 @default.
• W2128187135 hasAuthorship W2128187135A5038451587 @default.
• W2128187135 hasAuthorship W2128187135A5059711428 @default.
• W2128187135 hasAuthorship W2128187135A5060363489 @default.
• W2128187135 hasAuthorship W2128187135A5070685325 @default.
• W2128187135 hasAuthorship W2128187135A5071724466 @default.
• W2128187135 hasAuthorship W2128187135A5076276301 @default.
• W2128187135 hasAuthorship W2128187135A5076726477 @default.
• W2128187135 hasConcept C159047783 @default.
• W2128187135 hasConcept C159654299 @default.
• W2128187135 hasConcept C16005928 @default.
• W2128187135 hasConcept C161191863 @default.
• W2128187135 hasConcept C203014093 @default.
• W2128187135 hasConcept C2776960273 @default.
• W2128187135 hasConcept C2778461978 @default.
• W2128187135 hasConcept C2779548794 @default.
• W2128187135 hasConcept C2780868878 @default.
• W2128187135 hasConcept C41008148 @default.
• W2128187135 hasConcept C542903549 @default.
• W2128187135 hasConcept C71924100 @default.
• W2128187135 hasConceptScore W2128187135C159047783 @default.
• W2128187135 hasConceptScore W2128187135C159654299 @default.
• W2128187135 hasConceptScore W2128187135C16005928 @default.
• W2128187135 hasConceptScore W2128187135C161191863 @default.
• W2128187135 hasConceptScore W2128187135C203014093 @default.
• W2128187135 hasConceptScore W2128187135C2776960273 @default.
• W2128187135 hasConceptScore W2128187135C2778461978 @default.
• W2128187135 hasConceptScore W2128187135C2779548794 @default.
• W2128187135 hasConceptScore W2128187135C2780868878 @default.
• W2128187135 hasConceptScore W2128187135C41008148 @default.
• W2128187135 hasConceptScore W2128187135C542903549 @default.
• W2128187135 hasConceptScore W2128187135C71924100 @default.
• W2128187135 hasIssue "4" @default.
• W2128187135 hasLocation W21281871351 @default.
• W2128187135 hasLocation W21281871352 @default.
• W2128187135 hasOpenAccess W2128187135 @default.
• W2128187135 hasPrimaryLocation W21281871351 @default.
• W2128187135 hasRelatedWork W1490381735 @default.
• W2128187135 hasRelatedWork W1560414607 @default.
• W2128187135 hasRelatedWork W1591820460 @default.
• W2128187135 hasRelatedWork W1606912632 @default.
• W2128187135 hasRelatedWork W1899411185 @default.
• W2128187135 hasRelatedWork W195682249 @default.
• W2128187135 hasRelatedWork W2419379701 @default.
• W2128187135 hasRelatedWork W2591016783 @default.
• W2128187135 hasRelatedWork W2792226864 @default.
• W2128187135 hasRelatedWork W4298901412 @default.
• W2128187135 hasVolume "14" @default.
• W2128187135 isParatext "false" @default.
• W2128187135 isRetracted "false" @default.
• W2128187135 magId "2128187135" @default.
• W2128187135 workType "article" @default.